Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,347 | 13,196 | 12,554 | 11,041 | 13,905 |
| TOTAL | $9,267 | $14,039 | $13,622 | $12,618 | $14,893 |
| Non-Current Assets | |||||
| PPE Net | 340 | 549 | 595 | 648 | 701 |
| Other Non-Current Assets | 1,513 | 391 | 411 | 430 | 449 |
| TOTAL | $1,853 | $940 | $1,006 | $1,078 | $1,150 |
| Total Assets | $11,120 | $14,978 | $14,628 | $13,695 | $16,042 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,725 | 4,424 | 4,015 | 4,679 | 3,874 |
| Other current liabilities | 149 | 226 | 802 | 1,096 | 2,058 |
| TOTAL | $4,874 | $4,750 | $4,912 | $5,867 | $6,021 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,911 | 1,691 | 1,382 | 1,744 | 1,768 |
| TOTAL | $2,911 | $1,691 | $1,718 | $1,744 | $1,768 |
| Total Liabilities | $7,785 | $6,441 | $6,630 | $7,610 | $7,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,992 | 4,240 | 4,240 | 3,192 | 1,534 |
| Common Shares | 0 | 0 | 0 | 0 | 1 |
| Retained earnings | -274,787 | -269,134 | -263,838 | -259,394 | -253,947 |
| TOTAL | $3,335 | $8,537 | $7,997 | $6,085 | $8,253 |
| Total Liabilities And Equity | $11,120 | $14,978 | $14,628 | $13,695 | $16,042 |